Bavarian Nordic AS (WBO:BAVA)
€ 27.94 0.26 (0.94%) Market Cap: 2.20 Bil Enterprise Value: 1.91 Bil PE Ratio: 22.91 PB Ratio: 1.55 GF Score: 54/100

Bavarian Nordic A/S - Special Call Transcript

Oct 21, 2019 / 01:00PM GMT
Operator

Ladies and gentlemen, thank you for standing by and welcome to the Bavarian Nordic Q&A session. (Operator Instructions) Please be advised that this conference is being recorded. (Operator Instructions)

I'd now like to hand the conference over to your speaker today, Mr. Rolf Sass, CEO (sic) [Vice President, Investor Relations].

Rolf Sass SÃ;rensen;S;VP of IR;Communications
Bavarian Nordic A

¸ - /-&

Thank you, and welcome to this conference regarding Bavarian Nordic's acquisition of 2 commercial vaccines from GSK. With me, I have our Chief Financial Officer, Henrik Juuel; as well as our President and CEO, Paul Chaplin.

Before we start, I need to read the forward-looking statements. This presentation includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside our control, that could cause actual results to differ materially from the results discussed.

Forward-looking statements include statements regarding our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot